Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex Rescue for Inadequate Neostigmine Reversal
NCT05661409Phase 4Completed
- Sponsor
- Emory University
- Start
- Jul 2023
- Primary completion
- Aug 2024
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Emory University. Started Jul 2023; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT05661409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05661409.